Biocon gets MHRA UK nod for weight management injection Liraglutide Ruchika Sharma1 April 2024 2:22 PM ISTBangalore: Biocon Limited, through its European partner, Zentiva, has received approval from the Medicines and Healthcare Products Regulatory...
Biocon obtains approval for diabetes drug Liraglutide in UK Ruchika Sharma28 March 2024 2:30 PM ISTBengaluru: Biocon Limited, a global biopharmaceuticals company, has announced that the Company has received approval from the Medicines and...
Liraglutide can prevent PAD progression in patients with type 2 diabetes: STARDUST trial Medha Baranwal22 March 2024 7:45 PM ISTItaly: Compared with conventional treatment, liraglutide use over six months was associated with increased peripheral in patients with type 2 diabetes...
Liraglutide 3 mg per day Shows Efficacy in Weight Loss for Individuals with Bipolar Disorder: Study Dr Riya Dave11 March 2024 1:30 AM ISTObesity is prevalent among individuals with bipolar disorder (BD), posing significant health risks. Liraglutide, a medication indicated for chronic...
Liraglutide increases insulin sensitivity independent of weight loss in obese diabetics Dr. Kamal Kant Kohli16 Jan 2024 10:00 AM ISTUSA: A recent study published in Diabetes has shown weight loss-independent effect of liraglutide on insulin sensitivity in individuals with obesity...
Liraglutide does not impact heart rate or BP in diabetes patients during acute MI: Study Medha Baranwal11 Jan 2024 6:15 AM ISTChina: Liraglutide did not increase the heart rate of patients with diabetes during acute myocardial infarction (AMI) and did not lead to an increase...
Biocon collaborates with Juno Pharma for commercialization of diabetes treatment Liraglutide in Canada Ruchika Sharma7 Oct 2023 11:30 AM ISTBengaluru: Biocon Limited, an innovation-led global biopharmaceutical company, has announced the signing of a partnership agreement with Juno...
Issues with Weight loss? GLP1 agonists like Semaglutide, Liraglutide may increase risk of pancreatitis, gastroparesis and bowel obstruction Dr. Kamal Kant Kohli6 Oct 2023 10:30 AM ISTUS: Researchers at University of British Columbia have found in a new study that that use of glucagon-like peptide-1 agonists for weight loss compared...
Liraglutide modulates associative learning in obese individuals through GLP-1 receptor activation Dr. Kamal Kant Kohli25 Aug 2023 11:30 AM ISTGermany: A recent study published in Nature Metabolism has shown the potential of Liraglutide to restore impaired associative learning in individuals...
GLP-1 agonists may hasten progression of diabetic retinopathy Dr. Kamal Kant Kohli7 Aug 2023 11:30 AM ISTUSA: Studies have linked the use of GLP-1 receptor agonists with exacerbation of macular disease that frequently occurs in diabetes...
Liraglutide aids weight management among patients with suboptimal weight loss post-metabolic surgery Dr. Shravani Dali31 July 2023 9:15 AM ISTLiraglutide aids weight management in patients with suboptimal weight loss post metabolic surgery suggests a new study published in the JAMA...
Ensure safety, efficacy of applied Synthetic product: CDSCO panel Tells Sun Pharma for Liraglutide Injection Dr. Divya Colin27 July 2023 6:00 PM ISTNew Delhi: Rejecting the request presented by drug major Sun Pharma for a clinical trial waiver for glucagon-like peptide-1 analog Liraglutide...
